A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 35,061 shares of IART stock, worth $831,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,061
Previous 35,061 -0.0%
Holding current value
$831,296
Previous $1.02 Million 37.61%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.14 - $34.72 $150,410 - $225,680
6,500 Added 22.76%
35,061 $1.02 Million
Q1 2024

May 15, 2024

BUY
$33.4 - $45.2 $953,937 - $1.29 Million
28,561 New
28,561 $1.24 Billion
Q4 2023

Aug 14, 2024

SELL
$34.21 - $44.59 $45,157 - $58,858
-1,320 Reduced 4.42%
28,561 $1.24 Billion
Q3 2023

Aug 14, 2024

SELL
$37.8 - $45.97 $69,514 - $84,538
-1,839 Reduced 5.8%
29,881 $1.14 Billion
Q1 2023

Aug 14, 2024

BUY
$52.61 - $60.49 $104,693 - $120,375
1,990 Added 6.69%
31,720 $1.82 Billion
Q4 2022

Aug 14, 2024

BUY
$42.17 - $58.6 $193,982 - $269,560
4,600 Added 18.3%
29,730 $1.67 Billion
Q2 2022

Aug 14, 2024

BUY
$53.86 - $66.52 $198,204 - $244,793
3,680 Added 17.16%
25,130 $1.36 Billion
Q1 2022

Aug 14, 2024

SELL
$62.86 - $69.24 $855,587 - $942,425
-13,611 Reduced 38.82%
21,450 $1.38 Billion
Q4 2021

Aug 30, 2024

SELL
$62.47 - $73.25 $392,936 - $460,742
-6,290 Reduced 22.67%
21,450 $1.44 Billion
Q3 2021

Aug 30, 2024

SELL
$64.97 - $76.19 $475,645 - $557,786
-7,321 Reduced 20.88%
27,740 $1.9 Billion
Q3 2019

Aug 30, 2024

SELL
$53.29 - $64.59 $15,987 - $19,377
-300 Closed
0 $0
Q2 2019

Aug 30, 2024

SELL
$46.45 - $55.85 $1.61 Million - $1.94 Million
-34,761 Reduced 99.14%
300 $16.8 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.98B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.